Surveillance strategy according to age after endoscopic resection of early gastric cancer
- 367 Downloads
Whether surveillance strategy after curative endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) differs in young patients is unclear. This study aimed to evaluate the risk of metachronous and extragastric recurrence in young patients with EGC after curative ESD.
We retrospectively enrolled 1237 consecutive patients who underwent curative ESD for EGC from 2005 to 2014 at a single tertiary hospital. The patients were divided into group 1 (<50 years of age, n = 86), group 2 (age 50–74, n = 985), or group 3 (≥75 years of age, n = 166). The clinical characteristics and outcomes were compared among the three age groups.
Group 1 had more frequent Helicobacter pylori infection (P < 0.001), less frequent intestinal metaplasia (P = 0.021), and more frequent undifferentiated tumors (P = 0.039). Although the 5-year risk of developing metachronous recurrence appeared to be lower in group 1 (2.7%) than in groups 2 (8.6%) or 3 (8.7%), the risk became quite similar at the 7-year follow-up (6.4, 12.7, and 8.7% for groups 1, 2, and 3, respectively; P = 0.409 by log-rank test). Extragastric recurrences developed in only 2 cases in group 2 (0.2%).
Surveillance for metachronous and extragastric recurrence after curative ESD in patients <50 years of age should not be different from that in patients ≥50 years of age. Endoscopic surveillance for metachronous recurrence should be continued for longer than 5 years, even in young patients.
KeywordsEarly gastric cancer Endoscopic submucosal dissection Surveillance Metachronous gastric cancer Young patients
This work was supported by a Grant from the Promising-Pioneering Researcher Program through Seoul National University in 2015.
Compliance with ethical standards
Dr. Hyo-Joon Yang, Dr. Sang Gyun Kim, Dr. Joo Hyun Lim, Dr. Ji Min Choi, Dr. Sooyeon Oh, Dr. Jae Yong Park, Dr. Seung Jun Han, Dr. Jung Kim, Dr. Hyunsoo Chung, and Dr. Hyun Chae Jung have no conflicts of interest or financial ties to disclose.
- 4.Matsuda A, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H, Japan Cancer Surveillance Research G (2014) Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 44:388–396CrossRefPubMedGoogle Scholar
- 11.Park CH, Lee H, Kim DW, Chung H, Park JC, Shin SK, Hyung WJ, Lee SK, Lee YC, Noh SH (2014) Clinical safety of endoscopic submucosal dissection compared with surgery in elderly patients with early gastric cancer: a propensity-matched analysis. Gastrointest Endosc 80:599–609CrossRefPubMedGoogle Scholar
- 16.Choi J, Kim SG, Yoon H, Im JP, Kim JS, Kim WH, Jung HC (2014) Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma. Clin Gastroenterol Hepatol 12(793):800Google Scholar
- 17.Japanese Gastric Cancer Association (2011) Japanese classification of gastric carcinoma, 3rd edn. Gastric Cancer 14:101–112Google Scholar
- 23.Abe S, Oda I, Suzuki H, Nonaka S, Yoshinaga S, Nakajima T, Sekiguchi M, Mori G, Taniguchi H, Sekine S, Katai H, Saito Y (2015) Long-term surveillance and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection. Endoscopy 47:1113–1118CrossRefPubMedGoogle Scholar